Helen Sabzevari, President and CEO at PRECIGEN, INC. (PGEN), sold 6,960 shares at $3.59 ($25K) on 2022-01-05, disclosed to the SEC on 2022-01-06.
Scheduled sale ($25k) by President and CEO under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $3.59 | 1,357 | $5K | 19.5% |
| 2 | $3.59 | 5,603 | $20K | 80.5% |
| Total | $3.59 avg | 6,960 | $25K | 100% |
| Filing → |
| PGEN | SELL | 2023-08-25 | $236K | — | Filing → |
| PGEN | SELL | 2023-08-18 | $185K | — | Filing → |
| PGEN | SELL | 2023-08-11 | $119K | — | Filing → |